MIRANDA FELTY: Open Payments
NPI 1265871545 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,566 in 272 payments from 21 companies in 2025. Trend: 2023 $2,699 · 2024 $3,618 · 2025 $4,566
Food & beverage: $4,467Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 65 | $1,013 |
| ABBVIE INC. | 50 | $985 |
| Madrigal Pharmaceuticals | 14 | $498 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 34 | $418 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $256 |
| Regeneron Healthcare Solutions, Inc. | 13 | $230 |
| Celltrion USA Inc. | 13 | $205 |
| Novo Nordisk Inc | 7 | $197 |
| Ardelyx, Inc. | 10 | $164 |
| Ipsen Biopharmaceuticals, Inc | 8 | $126 |
Products named: TREMFYA, REZDIFFRA, XIFAXAN, RINVOQ, DUPIXENT, LINZESS, ENTYVIO, VEGZELMA.
Industry payments across PA — which companies pay providers there.
